Handbook of Nanomaterials for Cancer Theranostics. Micro and Nano Technologies

  • ID: 4465328
  • Book
  • 606 Pages
  • Elsevier Science and Technology
1 of 4

Handbook of Nanomaterials for Cancer Theranostics focuses on recent developments in advanced theranostic nanomedicines from a chemical and biological perspective where the advantages of theranostics are achieved by combining multiple components. The authors explore the pros and cons of theranostic nanomaterials developed in cancer research in the last 15 years, with the different strategies compared and scrutinized. In addition, the book explores how nanomaterials may overcome the regulatory hurdles facing theranostic nanomedicines.

This is an important research reference for postgraduates and researchers in nanomedicine and cancer research who want to learn more on how nanomaterials can help create more effective cancer treatments.

  • Highlights the development of smart theranostic nanomaterials to tackle biomedical problems in cancer therapy and diagnostics
  • Explores the regulatory hurdles facing theranostic nanomedicine
  • Discusses how the use of nanomaterials can help create more effective cancer treatments

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Note: Product cover images may vary from those shown
2 of 4
Chapter 1: The Emerging Role of Multifunctional Theranostic Materials in Cancer Nanomedicine

Chapter 2: Self-Assembled Nanogels: From Particles to Scaffolds and Membranes

Chapter 3: Single and Multiphoton Responsive Nanomaterials for the Investigation of Cancer Microenvironment

Chapter 4: Graphene as 2D Nano-Theranostic Materials for Cancer

Chapter 5: Applications of Plasmonic Nanomaterials for Phototriggered Theranostics

Chapter 6: Bioengineered Ferritin Nanoprobes for Cancer Theranostics

Chapter 7: The Role of Nanoscience in Cancer Diagnosis

Chapter 8: Nanotheranostics and Their Potential in the Management of Metastatic Cancer

Chapter 9: Targeted Nanotheranostics for Selective Drug Delivery in Cancer

Chapter 10: Considerations for the Human Health Implications of Nanotheranostics

Chapter 11: Nanomaterials for Theranostics of Gastric Cancer

Chapter 12: Nanomaterial Based Photo-Triggered Drug Delivery Strategies for Cancer Theranostics Bio-Nano Interactions

Chapter 14: Inorganic Nanotheranostic Platforms for Rapid and Reliable Molecular Profiling of Diseases

Chapter 15: Hydrogels as a New Platform to Recapitulate the Tumor Microenvironment

Chapter 16: Lipid-Based Nanosystems for the Delivery of siRNA: Challenges and Trends

Chapter 17: Multiparametric Preclinical Assessment of Theranostics Materials

Chapter 18: RNAi Nanomaterials and Nanovehicles: Inorganic Nanoparticles for RNAi

Chapter 19: Theranostic Magnetic Nanoparticles as Molecular Imaging Agents for siRNA Delivery
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Conde, Joao
Joao Conde is an independent researcher formally at the Massachusetts Institute of Technology, USA, and Queen Mary University, London, UK. His research interests include (i) biofunctionalization of multifunctional metal nanoparticles with DNA/RNA, siRNA, drugs, dendrimers, fluorescent dyes, polymers, proteins/peptides and antibodies for (ii) cancer therapy and (iii) diagnostics; (iv) in vitro and in vivo applications of new nanomaterials and (v) nanoparticles toxicity/biocompatibility studies. He has published 50 articles in peer-reviewed articles and sits on the Editor Board of two journals.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown